{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:55:26Z","timestamp":1791899726096,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Dongguan Social Science and Technology Development (General) Project","award":["(20231800904962) (20231800939032) (20231800939022) (20231800939232)"],"award-info":[{"award-number":["(20231800904962) (20231800939032) (20231800939022) (20231800939232)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10157-025-02718-4","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T10:37:00Z","timestamp":1752489420000},"page":"1724-1733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanism of RBM15 in high glucose-induced pyroptosis of renal tubular epithelial cells"],"prefix":"10.1007","volume":"29","author":[{"given":"Jian","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Bo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Lin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-sheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6480-2832","authenticated-orcid":false,"given":"Fei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"2718_CR1","doi-asserted-by":"publisher","first-page":"1497449","DOI":"10.1155\/2021\/1497449","volume":"2021","author":"N Samsu","year":"2021","unstructured":"Samsu N. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int. 2021;2021:1497449. https:\/\/doi.org\/10.1155\/2021\/1497449.","journal-title":"Biomed Res Int"},{"issue":"Suppl 1","key":"2718_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14007","volume":"22","author":"NM Selby","year":"2020","unstructured":"Selby NM, Taal MW. An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020;22(Suppl 1):3\u201315. https:\/\/doi.org\/10.1111\/dom.14007.","journal-title":"Diabetes Obes Metab"},{"key":"2718_CR3","doi-asserted-by":"publisher","first-page":"114252","DOI":"10.1016\/j.biopha.2023.114252","volume":"159","author":"Q Hu","year":"2023","unstructured":"Hu Q, Chen Y, Deng X, Li Y, Ma X, Zeng J, et al. Diabetic nephropathy: focusing on pathological signals, clinical treatment, and dietary regulation. Biomed Pharmacother. 2023;159:114252. https:\/\/doi.org\/10.1016\/j.biopha.2023.114252.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"2718_CR4","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.7150\/thno.71086","volume":"12","author":"Z Rao","year":"2022","unstructured":"Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao C, et al. Pyroptosis in inflammatory diseases and cancer. Theranostics. 2022;12(9):4310\u201329. https:\/\/doi.org\/10.7150\/thno.71086.","journal-title":"Theranostics"},{"issue":"1","key":"2718_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12967-023-04350-w","volume":"21","author":"M Yan","year":"2023","unstructured":"Yan M, Li W, Wei R, Li S, Liu Y, Huang Y, et al. Identification of pyroptosis-related genes and potential drugs in diabetic nephropathy. J Transl Med. 2023;21(1):490. https:\/\/doi.org\/10.1186\/s12967-023-04350-w.","journal-title":"J Transl Med"},{"issue":"2","key":"2718_CR6","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3892\/etm.2021.10246","volume":"22","author":"Y Wang","year":"2021","unstructured":"Wang Y, Gou R, Yu L, Wang L, Yang Z, Guo Y, et al. Activation of the NLRC4 inflammasome in renal tubular epithelial cell injury in diabetic nephropathy. Exp Ther Med. 2021;22(2):814. https:\/\/doi.org\/10.3892\/etm.2021.10246.","journal-title":"Exp Ther Med"},{"issue":"11","key":"2718_CR7","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1002\/tox.23917","volume":"38","author":"Y Qin","year":"2023","unstructured":"Qin Y, Wu S, Zhang F, Zhou X, You C, Tan F. N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway. Environ Toxicol. 2023;38(11):2772\u201382. https:\/\/doi.org\/10.1002\/tox.23917.","journal-title":"Environ Toxicol"},{"issue":"1","key":"2718_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-022-00350-8","volume":"27","author":"J Lan","year":"2022","unstructured":"Lan J, Xu B, Shi X, Pan Q, Tao Q. WTAP-mediated N(6)-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy. Cell Mol Biol Lett. 2022;27(1):51. https:\/\/doi.org\/10.1186\/s11658-022-00350-8.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"2718_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74. https:\/\/doi.org\/10.1038\/s41392-020-00450-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"2718_CR10","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Hsu PJ, Chen YS, Yang YG. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28(6):616\u201324. https:\/\/doi.org\/10.1038\/s41422-018-0040-8.","journal-title":"Cell Res"},{"issue":"1","key":"2718_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s10020-023-00764-w","volume":"29","author":"S Qi","year":"2023","unstructured":"Qi S, Song J, Chen L, Weng H. The role of N-methyladenosine modification in acute and chronic kidney diseases. Mol Med. 2023;29(1):166. https:\/\/doi.org\/10.1186\/s10020-023-00764-w.","journal-title":"Mol Med"},{"key":"2718_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301\u201316. https:\/\/doi.org\/10.1146\/annurev-immunol-081022-021207.","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"2718_CR13","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18(9):2114\u201327. https:\/\/doi.org\/10.1038\/s41423-021-00740-6.","journal-title":"Cell Mol Immunol"},{"key":"2718_CR14","doi-asserted-by":"publisher","first-page":"998574","DOI":"10.3389\/fphar.2022.998574","volume":"13","author":"J Wan","year":"2022","unstructured":"Wan J, Liu D, Pan S, Zhou S, Liu Z. NLRP3-mediated pyroptosis in diabetic nephropathy. Front Pharmacol. 2022;13:998574. https:\/\/doi.org\/10.3389\/fphar.2022.998574.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2718_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/imr.12607","volume":"281","author":"JA Duncan","year":"2018","unstructured":"Duncan JA, Canna SW. The NLRC4 inflammasome. Immunol Rev. 2018;281(1):115\u201323. https:\/\/doi.org\/10.1111\/imr.12607.","journal-title":"Immunol Rev"},{"issue":"10","key":"2718_CR16","doi-asserted-by":"publisher","first-page":"e0164135","DOI":"10.1371\/journal.pone.0164135","volume":"11","author":"F Yuan","year":"2016","unstructured":"Yuan F, Kolb R, Pandey G, Li W, Sun L, Liu F, et al. Involvement of the NLRC4-inflammasome in diabetic nephropathy. PLoS ONE. 2016;11(10):e0164135. https:\/\/doi.org\/10.1371\/journal.pone.0164135.","journal-title":"PLoS ONE"},{"issue":"10","key":"2718_CR17","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1093\/nar\/gkw104","volume":"44","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44(10):e91. https:\/\/doi.org\/10.1093\/nar\/gkw104.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2718_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"issue":"2","key":"2718_CR19","doi-asserted-by":"publisher","first-page":"159580","DOI":"10.1016\/j.bbalip.2024.159580","volume":"1870","author":"X Cai","year":"2024","unstructured":"Cai X, Li X, Zhang M, Dong Z, Weng Y, Yu W. RBM15 promotes lipogenesis and malignancy in gastric cancer by regulating N6-methyladenosine modification of ACLY mRNA in an IGF2BP2-dependent manner. Biochim Biophys Acta Mol Cell Biol Lipids. 2024;1870(2):159580. https:\/\/doi.org\/10.1016\/j.bbalip.2024.159580.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"2","key":"2718_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3724\/abbs.2021016","volume":"54","author":"X Li","year":"2022","unstructured":"Li X, Lu L, Hou W, Huang T, Chen X, Qi J, et al. Epigenetics in the pathogenesis of diabetic nephropathy. Acta Biochim Biophys Sin (Shanghai). 2022;54(2):163\u201372. https:\/\/doi.org\/10.3724\/abbs.2021016.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"4","key":"2718_CR21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TW Tervaert","year":"2010","unstructured":"Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556\u201363. https:\/\/doi.org\/10.1681\/ASN.2010010010.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2718_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2337\/db16-0796","volume":"66","author":"RE Gilbert","year":"2017","unstructured":"Gilbert RE. Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease. Diabetes. 2017;66(4):791\u2013800. https:\/\/doi.org\/10.2337\/db16-0796.","journal-title":"Diabetes"},{"key":"2718_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.molimm.2022.02.008","volume":"144","author":"C Li","year":"2022","unstructured":"Li C, Su F, Liang Z, Zhang L, Liu F, Fan W, et al. Macrophage M1 regulatory diabetic nephropathy is mediated by m6A methylation modification of lncRNA expression. Mol Immunol. 2022;144:16\u201325. https:\/\/doi.org\/10.1016\/j.molimm.2022.02.008.","journal-title":"Mol Immunol"},{"issue":"1","key":"2718_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10020-023-00615-8","volume":"29","author":"J Fang","year":"2023","unstructured":"Fang J, Wu X, He J, Zhang H, Chen X, Zhang H, et al. RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4. Mol Med. 2023;29(1):23. https:\/\/doi.org\/10.1186\/s10020-023-00615-8.","journal-title":"Mol Med"},{"issue":"4","key":"2718_CR25","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.ymthe.2022.01.002","volume":"30","author":"L Jiang","year":"2022","unstructured":"Jiang L, Liu X, Hu X, Gao L, Zeng H, Wang X, et al. METTL3-mediated m(6)A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy. Mol Ther. 2022;30(4):1721\u201340. https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.002.","journal-title":"Mol Ther"},{"key":"2718_CR26","doi-asserted-by":"publisher","first-page":"1226962","DOI":"10.3389\/fimmu.2023.1226962","volume":"14","author":"Z Lin","year":"2023","unstructured":"Lin Z, Lv D, Liao X, Peng R, Liu H, Wu T, et al. CircUBXN7 promotes macrophage infiltration and renal fibrosis associated with the IGF2BP2-dependent SP1 mRNA stability in diabetic kidney disease. Front Immunol. 2023;14:1226962. https:\/\/doi.org\/10.3389\/fimmu.2023.1226962.","journal-title":"Front Immunol"},{"issue":"1","key":"2718_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6(1):128. https:\/\/doi.org\/10.1038\/s41392-021-00507-5.","journal-title":"Signal Transduct Target Ther"},{"key":"2718_CR28","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1017\/erm.2021.27","volume":"23","author":"Y Zuo","year":"2021","unstructured":"Zuo Y, Chen L, Gu H, He X, Ye Z, Wang Z, et al. GSDMD-mediated pyroptosis: a critical mechanism of diabetic nephropathy. Expert Rev Mol Med. 2021;23:e23. https:\/\/doi.org\/10.1017\/erm.2021.27.","journal-title":"Expert Rev Mol Med"},{"issue":"6","key":"2718_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41419-021-03813-6","volume":"12","author":"Y Hou","year":"2021","unstructured":"Hou Y, Wang Q, Han B, Chen Y, Qiao X, Wang L. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys. Cell Death Dis. 2021;12(6):523. https:\/\/doi.org\/10.1038\/s41419-021-03813-6.","journal-title":"Cell Death Dis"},{"key":"2718_CR30","doi-asserted-by":"publisher","first-page":"5584894","DOI":"10.1155\/2023\/5584894","volume":"2023","author":"S Zheng","year":"2023","unstructured":"Zheng S, Zhang K, Zhang Y, He J, Ouyang Y, Lang R, et al. Human umbilical cord mesenchymal stem cells inhibit pyroptosis of renal tubular epithelial cells through miR-342-3p\/Caspase1 signaling pathway in diabetic nephropathy. Stem Cells Int. 2023;2023:5584894. https:\/\/doi.org\/10.1155\/2023\/5584894.","journal-title":"Stem Cells Int"},{"issue":"1","key":"2718_CR31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12882-024-03741-5","volume":"25","author":"Q Li","year":"2024","unstructured":"Li Q, Mu S. FTO mediates the diabetic kidney disease progression through regulating the m(6)A modification of NLRP3. BMC Nephrol. 2024;25(1):345. https:\/\/doi.org\/10.1186\/s12882-024-03741-5.","journal-title":"BMC Nephrol"},{"issue":"1","key":"2718_CR32","doi-asserted-by":"publisher","first-page":"11994","DOI":"10.1038\/s41598-022-15607-7","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Yu W, Xiong H, Yuan F. Circ_0000181 regulates miR-667-5p\/NLRC4 axis to promote pyroptosis progression in diabetic nephropathy. Sci Rep. 2022;12(1):11994. https:\/\/doi.org\/10.1038\/s41598-022-15607-7.","journal-title":"Sci Rep"},{"issue":"1","key":"2718_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/jdi.13660","volume":"13","author":"S Wen","year":"2022","unstructured":"Wen S, Deng F, Li L, Xu L, Li X, Fan Q. VX-765 ameliorates renal injury and fibrosis in diabetes by regulating caspase-1-mediated pyroptosis and inflammation. J Diabetes Investig. 2022;13(1):22\u201333. https:\/\/doi.org\/10.1111\/jdi.13660.","journal-title":"J Diabetes Investig"},{"issue":"11","key":"2718_CR34","doi-asserted-by":"publisher","first-page":"7305","DOI":"10.1007\/s12035-019-1595-1","volume":"56","author":"Y Xie","year":"2019","unstructured":"Xie Y, Castro-Hernandez R, Sokpor G, Pham L, Narayanan R, Rosenbusch J, et al. RBM15 modulates the function of chromatin remodeling factor BAF155 through RNA methylation in developing cortex. Mol Neurobiol. 2019;56(11):7305\u201320. https:\/\/doi.org\/10.1007\/s12035-019-1595-1.","journal-title":"Mol Neurobiol"},{"issue":"7","key":"2718_CR35","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2174\/1568009616666160112105706","volume":"16","author":"M Hu","year":"2016","unstructured":"Hu M, Yang Y, Ji Z, Luo J. RBM15 functions in blood diseases. Curr Cancer Drug Targets. 2016;16(7):579\u201385. https:\/\/doi.org\/10.2174\/1568009616666160112105706.","journal-title":"Curr Cancer Drug Targets"},{"issue":"9","key":"2718_CR36","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41556-023-01213-w","volume":"25","author":"X Dou","year":"2023","unstructured":"Dou X, Xiao Y, Shen C, Wang K, Wu T, Liu C, et al. RBFOX2 recognizes N(6)-methyladenosine to suppress transcription and block myeloid leukaemia differentiation. Nat Cell Biol. 2023;25(9):1359\u201368. https:\/\/doi.org\/10.1038\/s41556-023-01213-w.","journal-title":"Nat Cell Biol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02718-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02718-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02718-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T09:29:26Z","timestamp":1764235766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02718-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2718"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02718-4","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}